(Q42502255)

1 November 2017

title

Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation (English)

1 reference

1 November 2017

1 reference

1 reference

12

Hans W Sollinger

1 reference

1 November 2017

10

Jon S Odorico

1 reference

1 November 2017

9

Yolanda T Becker

1 reference

1 November 2017

5

John D Pirsch

1 reference

1 November 2017

6

Bryan N Becker

1 reference

1 November 2017

13

Stuart J Knechtle

1 reference

1 November 2017

Rolf N Barth

1

1 reference

1 November 2017

Christina A Janus

2

1 reference

1 November 2017

Christine A Lillesand

3

1 reference

1 November 2017

Nancy A Radke

4

1 reference

1 November 2017

Luis A Fernandez

7

1 reference

1 November 2017

L Thomas Chin

8

1 reference

1 November 2017

Anthony M D'Alessandro

11

1 reference

1 November 2017

language of work or name

1 reference

1 November 2006

1 reference

1 November 2017

published in

Transplant International

1 reference

1 November 2017

volume

19

1 reference

1 November 2017

issue

11

1 reference

1 November 2017

page(s)

885-892

1 reference

CAMPATH: from concept to clinic

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Sirolimus monotherapy following Campath-1H induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

The use of Campath-1H as induction therapy in renal transplantation: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Campath-1H in renal transplantation: The University of Wisconsin experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

Immunosuppressive treatment and progression of histologic lesions in kidney allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2006.00388.X

10.1111/J.1432-2277.2006.00388.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference